Latest News - Retina

Tuesday, September 19, 2017 | Clinical Trials, Retina, Ophthotech

Ophthotech Provides Update on Zimura Complement Programs for Treatment of Eye Diseases

Ophthotech announced the initiation of an open-label phase 2a clinical trial of Zimura (avacincaptad pegol), the company’s complement factor C5 inhibitor, in patients with wet age-related macula…

Read the full story

Tuesday, September 19, 2017 | Medical Studies, Retina

Laser May Be Safer Than Bevacizumab in Babies With Acute-Phase ROP

Babies with acute-phase retinopathy of prematurity (ROP) who are treated with bevacizumab have more long-term eye problems than babies treated with laser, according to a new randomized controlled tria…

Read the full story

Monday, September 11, 2017 | Retina, Alimera Sciences

Illuvien Now Available in Ireland for the Treatment of Chronic DME

Iluvien (190µg fluocinolone acetonide (FAc) intravitreal implant in applicator) is being made available in Ireland following an agreement between the healthcare provider Vhi and Iluvien’s …

Read the full story

Monday, September 11, 2017 | Clinical Trials, Retina, AMD, Genentech

Genentech's Lampalizumab Fails Phase 3 Study for Geographic Atrophy

Genentech announced that the primary endpoint has not been met in Spectri, the first of two phase 3 studies evaluating the safety and efficacy of lampalizumab, an investigational medicine for the trea…

Read the full story

Monday, September 11, 2017 | Medical Studies, Retina

Ranibizumab Beats Laser for Diabetic Retinopathy

Ranibizumab treats proliferative diabetic retinopathy more effectively than laser photocoagulation, researchers reported at the 17th EURETINA Congress. The finding challenges lasers as the standard of…

Read the full story

Monday, September 11, 2017 | Medical Studies, Retina

Retina Specialists Seek to Stem Myopia Epidemic

In light of the increasing prevalence of myopia in certain parts of the world, ophthalmologists should advise parents on ways to curb the development of myopia in children and intervene early if myopi…

Read the full story

Friday, September 01, 2017 | Retina, Genentech

EURETINA 2017: Genentech Ophthalmology Data Highlights

Genentech released teh data it will be presenting at the European Society of Retina Specialists (EURETINA) meeting on September 7-10 in Barcelona. Below are key takeaways from the EURETINA 2017 stu…

Read the full story

Friday, September 01, 2017 | Earnings & Financials, Retina, NightstaRx

Nightstar Files Registration Statement For Proposed Initial Public Offering

Nightstar Therapeutics a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, announced that it has filed a registration statement on Form F-1 with the U.S. S…

Read the full story

Friday, September 01, 2017 | Retina

Vision Gains From Aflibercept for Diabetic Macular Edema Persist for 5 Years

As-needed aflibercept treatment maintains vision gains in patients with diabetic macular edema (DME) through 5 years of treatment, even with reduced aflibercept dosing in the later years, according to…

Read the full story

Monday, August 28, 2017 | Clinical Trials, Retina, Second Sight Medical Products

Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study

Second Sight Medical Products announced that it has received conditional approval from the FDA to begin the Orion Cortical Visual Prosthesis System feasibility clinical study. The conditional approval…

Read the full story

Thursday, August 24, 2017 | Clinical Trials, Retina, AMD

Apellis Pharmaceuticals Announces APL-2 Met its Primary Endpoint in a Phase 2 Study in Patients with Geographic Atrophy

Apellis Pharmaceuticals announced that its complement C3 inhibitor, APL-2, met its primary endpoint in a phase 2 clinical trial (FILLY) in patients with geographic atrophy (GA) associated with age-rel…

Read the full story

Monday, August 21, 2017 | Medical Studies, Retina

Early, Late Outcomes of Therapy for Diabetic Macular Edema Correlate

Early vision gains correlate with long-term visual outcomes in patients with diabetic macular edema (DME) treated with bevacizumab or dexamethasone implants, according to results from the BEVORDEX cli…

Read the full story

Thursday, August 17, 2017 | Medical Studies, Retina

First Patient Enrolled in USH2A Natural History Study

The first patient has been enrolled in a 4-year natural history study of people with mutations in the USH2A gene which are the leading cause of the combined vision and hearing loss associated with Ush…

Read the full story

Wednesday, August 16, 2017 | Retina, AMD, Opthea

New Anti-VEGF Drug Promising for Wet Macular Degeneration

A new antivascular endothelial growth-factor (VEGF) drug, OPT-302 (Opthea), appears to be safe and shows signs of effectiveness in the treatment of neovascular age-related macular degeneration, new re…

Read the full story

Tuesday, August 15, 2017 | Medical Studies, Retina

UofL Researchers Discover Procedure to Regenerate Dormant Cone Cells, Potentially to Improve Vision in Retinitis Pigmentosa

Researchers at the University of Louisville have discovered a way to revitalize cone receptors that have deteriorated as a result of retinitis pigmentosa (RP). Working with animal models, Henry J. Kap…

Read the full story
Load More